Mission Point Nsg & Phy Rehab Ctr Of Warren | |
11525 E Ten Mile Rd, Warren, Michigan 48089 | |
(586) 759-0700 | |
Name | Mission Point Nsg & Phy Rehab Ctr Of Warren |
---|---|
Location | 11525 E Ten Mile Rd, Warren, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 178 |
Occupancy Rate | 70.51% |
Medicare ID (CCN) | 235259 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | For Profit - Corporation |
NPI Number | 1316536790 |
Organization Name | MISSION POINT OF WARREN LLC |
Address | 11525 E 10 Mile Rd, Warren, MI 48089 |
Phone Number | 586-759-0700 |
News Archive
Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
The legislation, which would focus its legal protection on providers who participate in Medicare and Medicaid, is designed to encourage the adoption of health information technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced Pharm-Olam International (POI), a global Contract Research Organization (CRO), signed a multi-year, multi-million dollar contract standardizing on the cloud-based unified clinical research platform, DATATRAK ONE.
A*STAR's Bioprocessing Technology Institute has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer.
› Verified 3 days ago
NPI Number | 1538102769 |
Organization Name | SSC WARREN OPERATING COMPANY LLC |
Doing Business As | WARREN WOODS HEALTH AND REHABILITATION CENTER |
Address | 11525 East Ten Mile Road, Warren, MI 48089 |
Phone Number | 586-759-0700 |
News Archive
Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
The legislation, which would focus its legal protection on providers who participate in Medicare and Medicaid, is designed to encourage the adoption of health information technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced Pharm-Olam International (POI), a global Contract Research Organization (CRO), signed a multi-year, multi-million dollar contract standardizing on the cloud-based unified clinical research platform, DATATRAK ONE.
A*STAR's Bioprocessing Technology Institute has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
The legislation, which would focus its legal protection on providers who participate in Medicare and Medicaid, is designed to encourage the adoption of health information technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced Pharm-Olam International (POI), a global Contract Research Organization (CRO), signed a multi-year, multi-million dollar contract standardizing on the cloud-based unified clinical research platform, DATATRAK ONE.
A*STAR's Bioprocessing Technology Institute has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 3 |
Total Amount of Fines in Dollars | $52318 |
Number of Payment Denials | 1 |
Total Number of Penalties | 4 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 8.06 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.15 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.2 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.66 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.75 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 7.33 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.63 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.99 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 14.14 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 28.94 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.75 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 24.7 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.65 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.21 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.94 | 95.98 |
Percentage of short-stay residents who made improvements in function | 68.52 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.06 | 82.93 |
News Archive
Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
The legislation, which would focus its legal protection on providers who participate in Medicare and Medicaid, is designed to encourage the adoption of health information technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced Pharm-Olam International (POI), a global Contract Research Organization (CRO), signed a multi-year, multi-million dollar contract standardizing on the cloud-based unified clinical research platform, DATATRAK ONE.
A*STAR's Bioprocessing Technology Institute has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer.
› Verified 3 days ago
Mission Point Nsg & Phy Rehab Ctr Of Warren Location: 11525 E Ten Mile Rd, Warren, Michigan 48089 Phone: (586) 759-0700 | |
Advantage Living Center - Warren Location: 12250 E 12 Mile Rd, Warren, Michigan 48093 Phone: (586) 751-6200 | |
Windemere Park Health And Rehab Center Location: 31800 Van Dyke Avenue, Warren, Michigan 48093 Phone: (586) 722-2600 |